Explore more publications!
Austria Health Focus
Got News to Share?

Press Releases

Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements
Apr. 14, 2026

Vetter Strengthens its Global Clinical Manufacturing Network with Strategic Site Enhancements

Neutral EIN Presswire
Pluxee delivers strong margin expansion and cash generation in H1 Fiscal 2026, reaffirming all full‑year objectives
5 hours ago

Pluxee delivers strong margin expansion and cash generation in H1 Fiscal 2026, reaffirming all full‑year objectives

Indeterminate GlobeNewswire, Inc.
AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
Apr. 1, 2026

AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure

Indeterminate GlobeNewswire, Inc.
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
Apr. 14, 2026

Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

Indeterminate GlobeNewswire, Inc.
Proxygen Appoints Chiara Conti, Ph.D. as Chief Scientific Officer to Drive Clinical Translation and Expand Induced Proximity Platform Beyond Degradation
Mar. 31, 2026

Proxygen Appoints Chiara Conti, Ph.D. as Chief Scientific Officer to Drive Clinical Translation and Expand Induced Proximity Platform Beyond Degradation

Indeterminate GlobeNewswire, Inc.
Cyclist to Ride Solo Across Australia for Mental Health Awareness
Mar. 31, 2026

Cyclist to Ride Solo Across Australia for Mental Health Awareness

Neutral EIN Presswire
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
Mar. 27, 2026

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference

Indeterminate GlobeNewswire, Inc.
Attune & Frontier Energy Support CEC-Funded 3C-BEACH Study on Electrification, IAQ, and Health
Mar. 26, 2026

Attune & Frontier Energy Support CEC-Funded 3C-BEACH Study on Electrification, IAQ, and Health

Neutral EIN Presswire
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
Mar. 26, 2026

HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics

Indeterminate GlobeNewswire, Inc.
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Mar. 26, 2026

Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results

Indeterminate GlobeNewswire, Inc.
National Workgroup Identifies High Value Opportunities at Intersection of Pharmacy Care and Interoperability
Mar. 23, 2026

National Workgroup Identifies High Value Opportunities at Intersection of Pharmacy Care and Interoperability

Indeterminate GlobeNewswire, Inc.
Causeway Therapeutics Presents Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis at RNA Leaders Europe 2026
Mar. 19, 2026

Causeway Therapeutics Presents Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis at RNA Leaders Europe 2026

Indeterminate GlobeNewswire, Inc.
Geistlich Awards Spartanburg, SC Periodontist with Trip to International Osteology Symposium Vienna 2026
Mar. 19, 2026

Geistlich Awards Spartanburg, SC Periodontist with Trip to International Osteology Symposium Vienna 2026

Neutral EIN Presswire
Argentina Officially Leaves World Health Organization
Mar. 18, 2026

Argentina Officially Leaves World Health Organization

Indeterminate MENAFN
Owner: Sawsan Dababneh

MENAFN

Indeterminate
Owned By Sawsan Dababneh through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Jordan, Amman
Owner Country Jordan

We welcome your feedback!
If you have comments or corrections, let us know.

Plastic Pellets Market Size to Reach USD 12.98 Bn by 2032 at 5.2% CAGR | Sustainable Resin Innovation Fuel Global Demand
Apr. 15, 2026

Plastic Pellets Market Size to Reach USD 12.98 Bn by 2032 at 5.2% CAGR | Sustainable Resin Innovation Fuel Global Demand

Neutral EIN Presswire
eHealth Exchange Demonstrates Real-World Patient Access Capability, Advancing CMS-Aligned Network Goals
Apr. 9, 2026

eHealth Exchange Demonstrates Real-World Patient Access Capability, Advancing CMS-Aligned Network Goals

Indeterminate GlobeNewswire, Inc.
Wood Pellet Market Size to Surpass USD 47.74 Billion by 2032, Shows New Maximize Market Research Analysis
Apr. 14, 2026

Wood Pellet Market Size to Surpass USD 47.74 Billion by 2032, Shows New Maximize Market Research Analysis

Neutral EIN Presswire
Akkodis and STACKIT enter strategic partnership for sovereign cloud transformation in Germany
Apr. 14, 2026

Akkodis and STACKIT enter strategic partnership for sovereign cloud transformation in Germany

Indeterminate GlobeNewswire, Inc.
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
Apr. 6, 2026

Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

Indeterminate GlobeNewswire, Inc.
Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA
Apr. 7, 2026

Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions